Abbott Laboratories Inc reported better-than-expected quarterly earnings yesterday on recovering sales of its nutritional products and improved profit margins for other business segments.
Sales of nutritional products, the company’s biggest product line which includes Similac infant formula and Ensure beverages for adults, rose 1.6 per cent to $1.73 billion, following declines in previous quarters.
